BIO WEST

Biowest manufactures lymphocyte separation media in two volumes: 100 mL and 500 mL. These products are specifically designed for isolating lymphocytes from blood samples in laboratory settings, enabling cell processing procedures. The devices are classified as Class A medical devices, indicating a low risk profile.

Biowest is headquartered in France. Its primary focus is on providing lymphocyte separation media for laboratory use, ensuring quality, efficiency, and traceability in cell processing applications. The company specializes in products that assist in isolating immune cells from blood samples.

Yes, Biowest’s devices are registered in the EU’s eudamed database, which is the official European Union registry for medical devices. This listing ensures transparency and compliance with EU regulatory requirements for Class A devices.

Biowest’s devices, including the lymphocyte separation media, are classified as Class A medical devices. This classification is determined by their intended use—low-risk procedures in laboratory settings—and aligns with EU regulatory frameworks, where Class A devices require minimal regulatory oversight.